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Background: The present analysis focuses on phenotypic and genotypic characterizations 
of efflux-mediated erythromycin resistance in Streptococcus pneumoniae due to an increase 
in macrolide resistance in S. pneumoniae worldwide.
Methods: We investigated the prevalence of efflux-mediated erythromycin resistance and 
its relevant genetic elements from 186 specimens of S. pneumonia isolated from clinical 
and normal flora from Tehran, Iran. The presence of erythromycin resistance genes was 
tested by PCR with two sets of primers, specific for erm(B) and mef(A/E), and their genetic 
elements with tetM, xis, and int genes. Isolates were typed with the BOX PCR method and 
tested for resistance to six antibiotics.
Results: Antibiotic susceptibility tests revealed that 100% and 47% isolates were resistant 
to tetracycline and erythromycin, respectively. The erythromycin and clindamycin double-
disc diffusion test for macrolide-lincosamide-streptograminB (MLSB) resistance phenotype 
showed 74 (84%) isolates with the constitutive MLSB phenotype and the remaining with 
the M phenotype. BOX PCR demonstrated the presence of 7 types in pneumococci with 
the M phenotype. Fourteen (16%) isolates with the M phenotype harbored mef(A/E), tetM, 
xis, and int genes.
Conclusion: The present results suggest dissemination of polyclonal groups of S. pneu-
moniae with the M phenotype carrying resistance genes attributed to transposon 2009.
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INTRODUCTION
Streptococcus pneumonia colonizes the human nasopharynx 
and is the leading causative agent of otitis media, respiratory in-
fection, bacteremia, and meningitis, leading to high morbidity 
and mortality worldwide [1, 2]. In recent years, treatment for S. 
pneumoniae has become difficult owing to the global rise in the 
prevalence of antibiotic resistance, particularly against first-line 
antibiotics such as erythromycin and penicillin [3].
 Macrolide resistance in S. pneumoniae is mediated by 2 major 
mechanisms: ribosomal modification by 23S rRNA methylation 
[4] and active drug efflux [5] encoded by erm(B) and mef genes, 
respectively. The macrolide efflux pump proteins belong to the 
major facilitator superfamily of transporters, and several mef 
genes have also been described in other microbial species [6].
 M phenotype, which is mediated by mef genes, was first demon-
strated in S. pneumonia and S. pyogenes. The 2 variants, mef(A) 
and mef(E), are 90% similar and were long regarded as a single 
gene class because they were not distinguishable by PCR [7, 8].
 The genetic elements for the two variants are carried on differ-
ent but related elements [7]. The mef(A) gene is carried on the 
defective transposon Tn1207.1 or the closely related Tn1207.3 
and mef(E) on the “macrolide efflux genetic assembly” (mega) 
element. Other mobile genetic elements have also been de-
scribed, such as the Tn916 family, which contains composite el-
ements, such as tetM plus mega (Tn2009), and tetM, erm(B), 
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and mega (Tn2010) [3].
 Distribution of these transposons and the genes carried by 
them vary in different geographic regions [9], thereby providing 
an indication towards the origin of antibiotic-resistant strains of S. 
pneumoniae. It is, therefore, important to understand the distri-
bution of macrolide resistance in different countries. In addition, 
analysis of the molecular genetics of erythromycin resistance by 
including the types of transposons and their resistance-confer-
ring genes in clinical and normal flora pneumococci isolates with 
M phenotype would add to our present knowledge of the molec-
ular epidemiology of S. pneumoniae.
METHODS
1. Specimen collection
The isolates were collected from patients admitted to the city 
hospitals and private laboratories in Tehran, Iran. The studies 
were carried out over a period of 24 months, from 2011 to 2013. 
Only one isolate per patient was included in the study. Naso-
pharynx normal flora isolates were collected from healthy peo-
ple. Patients who had any antibiotic treatment in the last 6 
months were excluded from the study. A consent form was filled 
by the participants. 
2. Species identification
Specimens were streaked on 5% sheep blood agar plate (Merck 
KGaA, Darmstadt, Germany) and were incubated for 24-48 hr 
at 37°C in a candle jar. Standard microbiological techniques us-
ing typical colonial appearance, hemolysis, Gram staining, bile 
solubility, and susceptibility to optochin (1 µg) discs were per-
formed for species identification. S. pneumonia ATCC 49619 
was used for quality control. The final identification was con-
firmed by PCR using species-specific primers for amplification 
of lytA gene. The primer sets used were lytA-F: CGGACTAC 
GCCTTTATATCG and lytA-R: GTTTCAATCGTCAAGCCGTT [10]. 
3. Macrolide resistance phenotypes
Isolates were primarily identified as macrolide-lincosamide-
streptograminB (MLSB)-resistant phenotypes by the double-disc 
diffusion method using erythromycin (15 µg) (Mast Diagnostics 
Ltd, Bootle, Merseyside, UK) and clindamycin (2 µg) (Mast Di-
agnostics Ltd) standards discs. Constitutive, inducible, or M 
phenotypes were determined by placing the clindamycin disc 
adjacent to erythromycin.  After 24-hr  incubation, flattened col-
onies around the clindamycin zone and in the area between the 
two discs (D zone) had an inducible MLSB (iMLSB) phenotype, 
whereas the absence of blunting indicated the presence of the 
constitutive MLSB (cMLSB) phenotype. The M phenotype was 
characterized by clindamycin susceptibility with no blunting of 
the inhibition zone around the clindamycin disc [11].
4. Macrolide resistance genotype
DNA extraction of pneumococcal isolates was done with peq-
GOLD Bacterial DNA Kit (peQlab, Erlangen, Germany). The erythro-
mycin resistance and genetic elements genes were detected by 
PCR with two sets of primers specific for erm(B), mef(A/E), and 
tetM (Table 1) [12]. The PCR amplicons were produced by an 
initial cycle at 95°C for 10 min, followed by 30 cycles of denatur-
ation at 94°C for 30 sec, annealing at 57°C for 30 sec, and exten-
sion at 72°C for 30 sec with a final extension at 72°C for 5 min.
 PCR-based confirmation for the presence of mef gene was 
performed with a set of primer pairs (Table 1) that also enabled 
recognition of the type of genetic organization of the transposon. 
The PCR program for int and xis genes were as follows: an initial 
cycle at 95°C for 10 min, followed by 30 cycles of denaturation 
at 94°C for 30 sec, annealing at 52°C for 30 sec, and extension 
at 72°C for 30 sec with a final extension at 72°C for 5 min.
5. Determination of antibiotic susceptibility
Isolates primarily identified as pneumococci with M phenotype 
were subsequently tested for resistance against tetracycline (30 
μg), oxacillin (1 µg), clindamycin (2 µg), cotrimoxazole (1.25/ 
23.75 µg), vancomycin (30 µg), and chloramphenicol (30 µg) 
(Mast Diagnostics Ltd) by employing the disc diffusion agar 
method.
 Minimum inhibitory concentrations (MICs) of erythromycin 
were determined by the Etest (Liofilchem, Via Scozia, Italy) 
method on Mueller-Hinton agar with 5% defibrinated sheep 
Table 1. List of oligonucleotide primers used
Gene Sequence (5´-3´) Product size (bp) References
erm(B) TGGTATTCCAAATGCGTAATG 745 [12]
CTGTGGTATGGCGGGTAAGT
mef(A/E) CAATATGGGCAGGGCAAG 317 [12]
AAGCTGTTCCAATGCTACGG
tetM GTGGACAAAGGTACAACGAG 406 [12]
CGGTAAAGTTCGTCACACAC
int GCGTGATTGTATCTCACT 1,046 [8]
GACGCTCCTGTTGCTTCT
xis AAGCAGACTGAGATTCCTA 193 [8]
GCGTCCAATGTATCTATAA
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blood according to the manufacturer’s instructions. All plates 
were incubated at 37°C for 20 hr. The MICs for penicillin for all 
isolates with the M phenotype were also determined by the Etest 
method. MIC results were interpreted according to the guide-
lines of the Clinical and Laboratory Standard Institute [13].
6. BOX-PCR
All pneumococcal isolates with the M phenotype were typed by us-
ing BOX-PCR with the boxA 5´-CTACGGCAAGGCGACGCTGACG-
3´primer [14].
 PCR for amplification was performed under the following con-
ditions: pre-denaturation at 95°C for 7 min, 30 cycles each of de-
naturation at 90°C for 30 sec, primer annealing at 48°C for 1 min, 
chain extension at 65°C for 8 min, and a single cycle extension at 
65°C for 16 min. After amplification, products were elecropho-
resed in a 1% agarose gel with 0.5×Tris-borate-EDTA at 100 V for 
3 hr. The gel was stained with ethidium bromide (1 mg/mL) and 
viewed with UV light. Banding patterns that differed from each 
other by more than three bands were examined visually. 
RESULTS
1. Bacterial isolates
In our study, 92 clinical and 94 normal flora isolates were identi-
fied as pneumococci. Antibiotic susceptibility results for erythro-
mycin revealed that 43 (46%) from clinical and 45 (49%) from 
normal flora isolates were resistant to erythromycin. Clinical iso-
lates were obtained from blood (15), cerebrospinal fluid (6), lung 
secretions (9), eyes (8), sinuses (1), trachea (1), and ears (3).
2. Phenotypic and genotypic detection of the M phenotype
The double-disc diffusion test with erythromycin and clindamy-
cin for the 88 test strains revealed that 74 (84%) indicated the 
cMLSB phenotype, and 14 (16%) were assigned to the M phe-
notype. These findings, together with the ranges of MICs of 
erythromycin, are summarized in Table 2. Amongst the isolates, 
erm(B) gene alone was detected in 39 (44%) and mef(A/E) 
in14 (16%) isolates, while 35 (40%) isolates harbored both 
erm(B) and mef(A/E) simultaneously as shown in Table 2. The 
association of tetM and mef gene was found in 100% of isolates 
with the M phenotype.
 To gain further insights into the 14 strains with the M pheno-
type carrying the mef(A/E) genetic elements, we investigated the 
presence of two genes, xis and int, associated with Tn2009. The 
Table 2. Macrolide resistance phenotypes and genotypes of 88 
erythromycin-resistant isolates of S. pneumoniae
Macrolide 







mef(A/E) M 1.5-16 14 (16)
erm(B) cMLSB ≥256 39 (44)
mef(A/E) + erm(B) cMLSB ≥256 35 (40)
Abbreviations: MIC, minimum inhibitory concentration; cMLSB, constitutive 
macrolide-lincosamide-streptograminB.
Table 3. Association of erythromycin resistance isolates with M phenotype, their resistance elements, presumed Tn type, and BOX PCR types
Strain No. Origin of sample Age range (yr) tetM erm(B) mef(A/E) xis int Tn type BOX type
1 Blood 61-90 + - + + + 2009 1
2 Pleura 61-90 + - + + + 2009 2
3 Blood 0-5 + - + + + 2009 3
4 Eye 30-60 + - + + + 2009 1
5 Sinus 6-15 + - + + + 2009 4
6 Normal flora 6-15 + - + + + 2009 5
7 Normal flora 6-15 + - + + + 2009 5
8 Normal flora 6-15 + - + + + 2009 6
9 Normal flora 6-15 + - + + + 2009 5
10 Normal flora 6-15 + - + + + 2009 6
11 Normal flora 6-15 + - + + + 2009 5
12 Normal flora 6-15 + - + + + 2009 6
13 Blood 0-5 + - + + + 2009 7
14 CSF 0-5 + - + + + 2009 1
Abbreviations: Tn, transposon; CSF, cerebrospinal fluid.
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results revealed that all isolates carrying the mef gene were also 
positive for xis and int, thus exhibiting association with Tn2009 
(Table 3). 
3. Antibiotic resistance 
All the resistant isolates with M phenotype were resistant to tet-
racycline (100%) and cotrimoxazole (100%), and 42% were 
also resistant to chloramphenicol, while they were all found to 
be susceptible to clindamycin and vancomycin. The erythromy-
cin MIC for 84% of isolates with cMLSB phenotype was ≥256 
μg/mL. The MIC for all of isolates with the M phenotype was 
1.5-16 μg/mL (Table 2). Furthermore, results obtained from MIC 
for penicillin indicated only one resistant isolate (≥2 μg/mL), 3 
isolates with high susceptibility (<0.1 μg/mL), and the remain-
ing within intermediate susceptibility (0.1-1.5 μg/mL).
4. Typing with BOX PCR
According to the BOX PCR typing method, the erythromycin-re-
sistant strains with M phenotype belonged to 3 common types 
with 10 isolates and 4 single types (Table 3). All normal flora 
samples were divided in two common types, whilst the clinical 
samples included one common type and four single types.
DISCSSION  
There has been an increase in the numbers of erythromycin-re-
sistant S. pneumoniae strains worldwide [3]. The previous year 
also witnessed a worldwide increase in the prevalence of efflux 
mechanisms (M phenotype) amongst the S. pneumoniae 
strains [15]. In line with this, our results show a high prevalence 
of resistance to macrolides (47%), and the M phenotype was 
found in 16% of the isolates, all of which carried mef(A/E). 
These values are much higher than that determined in other 
studies, 9.1% in Spain and 3.1% in France [9, 16] reporting lower 
prevalence of mef(A/E) among macrolide-resistant isolates. Our 
results are also consistent with the studies on pneumococcal 
macrolide resistance, which show that it is more prevalent in the 
United States and Canada, with a higher rate of M phenotype 
and mef(A/E) genotype compared with European countries [16].
 Almost 40% of the pneumococcal isolates obtained from Ko-
rea and South Africa have been reported to carry erm(B) and 
mef(A/E) genes [17, 18]. Moreover, other countries have also re-
ported, to lesser extent, simultaneous presence of the two genes 
[3, 7, 18, 19]. Overall, all the reports suggest an emergence of 
resistant pneumococci erm(B) and mef(E) genes worldwide.
 As expected, the present results showed that the isolates with 
erm(B) gene alone or with mef were highly resistant to erythro-
mycin. On the other hand, the strains with mef(A/E) alone 
showed low-level resistance to erythromycin, which is the typical 
characteristic of strains with the M phenotype [18, 20].
 Here, we showed that the isolates with M phenotype were as-
sociated with high rates of chloramphenicol, cotrimoxazole, and 
tetracycline resistance. In addition, penicillin remains a thera-
peutic choice for all of the isolates (10 intermediate and 1 resis-
tant), which were detected as susceptible, except for three pen-
icillin-resistant isolates. The results obtained are consistent with 
other reports suggesting concomitant resistance to erythromycin 
and other antibiotics with therapeutic options [20, 21]. Further-
more, we observed that all isolates with M phenotype were also 
resistant to tetracycline. The resistance to tetracycline has fre-
quently been associated with erythromycin [7].
 The high resistance rate to tetracycline might also be due to 
the presence of Tn2009 encoding genes conferring tetracycline 
and erythromycin resistance. All of the isolates with mef(A/E) 
were positive for int and xis by PCR. This combination of genes 
is characteristic of Tn2009, which is a Tn916-related transpo-
son. Cochetti et al. [8] have also reported the mega element as 
a major element carrying mef(A/E) gene. This transposon was 
detected in other studies as the genetic element conferring 
macrolide resistance in pneumococcal isolates [9, 22].
 Using BOX PCR typing, we showed the pneumococci with M 
phenotype in clinical isolates to be polyclonal, whereas normal 
flora isolates were clonally related. As reported earlier [16], the 
emergence of efflux mechanism of macrolide resistance is not 
clonally related in clinical isolates. They can, however, be trans-
ferred clonally. 
 In conclusion, the rate of macrolide resistance in our S. pneu-
moniae collection was high. Although the cMLSB phenotype 
predominates macrolide resistance in Iran, the M phenotype, 
appears to be emerging as an important factor in erythromycin-
resistant pneumococci. A majority of these isolates showed a 
high level of resistance to tetracycline, cotrimoxazole, and peni-
cillin, which makes treatment difficult. It is, therefore, necessary 
to collect data from various countries for the worldwide surveil-
lance on emergence of macrolide resistance in S. pneumoniae 
isolates.
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